EDAP TMS S.A. - ADR

$5.44

up-down-arrow $-0.01 (-0.18%)

As on 17-Jul-2026 09:30EDT

Market cap

info icon

$162 Mln

Revenue (TTM)

info icon

$63 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

23.1

Div. Yield

info icon

0 %

EDAP TMS S.A. - ADR Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 5.35 High: 5.51

52 Week Range

Low: 1.21 High: 5.51

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.2 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    44.46

  • EV/EBITDAEV/EBITDA information

    1165.8

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    37,481,986

10 Years Aggregate

CFO

$-8.62 Mln

EBITDA

$-27.25 Mln

Net Profit

$-22.52 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
EDAP TMS S.A. - ADR
65.2 13.9 51.4 269.7 -14.5 -1.9 5.2
BSE Sensex*
-9.1 -1.2 2.9 -3.6 5.7 6.2 10.5
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 17-Jul-2026  |  *As on 31-Aug-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
EDAP TMS S.A. - ADR
48.9 -57.8 -50.5 78.0 15.9 16.7 139.5
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
EDAP TMS S.A. - ADR
5.4 161.9 62.9 -38.9 -60.7 -400.5 -- 23.1
60.2 8,018.1 616.9 -75.1 1.7 -9.3 -- 10.2
14.4 9,638.1 6,561.1 -578.0 -4.5 -10.3 -- 1.7
365.1 9,761.6 2,589.3 222.4 -6.0 3 44.5 1.3
57.0 8,696.7 3,499.6 -71.2 0.5 -3.2 -- 3.8
177.0 10,905.5 612.8 -188.1 -30.6 -28.1 -- 16.4
101.0 6,577.5 1,556.3 275.3 24.6 22.9 24.1 5.0
90.9 5,403.2 1,579.2 145.6 14.3 8.9 37.2 3.2
323.4 12,752.7 1,504.9 160.6 13.6 10.9 79.4 8.4
178.8 9,947.9 785.1 41.5 9.9 2 251.8 4.9

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About EDAP TMS S.A. - ADR

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company...  operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France. 

  • Executive Chairman

    Mr. Marc Oczachowski

  • Executive Chairman

    Mr. Marc Oczachowski

  • Headquarters

    Vaulx-en-Velin

  • Website

    https://focalone.com

FAQs for EDAP TMS S.A. - ADR

The share price of EDAP TMS SA - ADR is $5.44 (NASDAQ) as of 17-Jul-2026 09:30 EDT. EDAP TMS SA - ADR has given a return of -14.55% in the last 3 years.

Since, TTM earnings of EDAP TMS SA - ADR is negative, P/E ratio is not available.
The P/B ratio of EDAP TMS SA - ADR is 23.08 times as on 17-Jul-2026, a 509 premium to its peers’ median range of 3.79 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-4.20
6.35
2024
-4.33
2.01
2023
-9.24
3.44
2022
-134.19
5.49
2021
295.70
4.14

The 52-week high and low of EDAP TMS SA - ADR are Rs 5.51 and Rs 1.21 as of 31-Aug-2026.

EDAP TMS SA - ADR has a market capitalisation of $ 162 Mln as on 17-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in EDAP TMS SA - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...